TCL Archive OMB To Seek Rescission In ’79 Appropriation For NIH; NCI Cut Would BE $29 Million; FY 1980 Budget Request Will Be $912.7 Million December 8, 1978
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
